GO:0031111 negative regulation of microtubule polymerization or depolymerization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031111 describes any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization or depolymerization.
• Microtubule growth can be negatively regulated by post-translational modifications such as glutamylation, which directly suppresses microtubule growth.
• Kinesin-8 motor proteins can actively depolymerize microtubules, providing a molecular model for negative regulation of microtubule dynamics.
• Neuronal microtubule nucleation is controlled by a cytosol-to-nucleus feedback loop, linking negative regulation to neuronal development.
• ARHGAP10 functions as a novel microtubule-associated protein that regulates osteoclast resorption, connecting microtubule dynamics to bone biology.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes that negatively regulate microtubule polymerization or depolymerization [1,2,6].
Description
Microtubules are dynamic cytoskeletal polymers that alternate between polymerization and depolymerization, and their proper regulation is essential for cell division, intracellular transport, and cell shape. The Gene Ontology term GO:0031111, negative regulation of microtubule polymerization or depolymerization, captures any process that stops, prevents, or reduces the frequency, rate or extent of these dynamic transitions. This term is distinct from positive regulation and from general microtubule organization, and it is used to annotate gene products that suppress microtubule dynamics. Researchers studying cytoskeletal control, mitosis, neuronal development, and cancer often need to identify and characterize negative regulators of microtubule polymerization or depolymerization [4,6]. Understanding this process at the molecular level has direct implications for drug discovery, because microtubule-targeting agents are widely used in oncology and neurology. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0031111, its mechanisms, key genes, disease links, and experimental models.
negative regulation of microtubule polymerization or depolymerization At A Glance
| GO ID | GO:0031111 |
|---|---|
| GO term | negative regulation of microtubule polymerization or depolymerization |
| Ontology | biological_process |
| Synonym | down regulation of microtubule polymerization or depolymerization; down-regulation of microtubule polymerization or depolymerization; downregulation of microtubule polymerization or depolymerization; inhibition of microtubule polymerization or depolymerization |
| Major function | Suppression of microtubule dynamic instability by reducing the rate or extent of polymerization or depolymerization |
| Related processes | Microtubule cytoskeleton organization, mitotic spindle assembly, neuronal development, osteoclast function |
| Example regulators | Glutamylation enzymes, kinesin-8 motors, ARHGAP10, PIK3C3, HYPK |
| Disease relevance | Cancer, neurodegeneration, bone disorders, autophagy-related pathologies |
What Is GO:0031111?
GO:0031111 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization or depolymerization. In other words, it encompasses molecular events that put the brakes on microtubule growth or shrinkage, thereby stabilizing or dampening microtubule dynamics. This negative regulation can occur through post-translational modifications, motor proteins, or signaling feedback loops that alter the balance between tubulin addition and loss [3,4,6].
Why Is negative regulation of microtubule polymerization or depolymerization Important in Cell Biology?
Negative regulation of microtubule polymerization or depolymerization is critical because uncontrolled microtubule dynamics lead to mitotic errors, defective neuronal transport, and impaired cell migration [3,4,6]. This process is a key node for therapeutic intervention, as many anticancer drugs either stabilize or destabilize microtubules. Understanding the negative regulators helps explain resistance mechanisms and provides new targets for precision medicine [4,7].
• Controls mitotic spindle dynamics and chromosome segregation fidelity.
• Regulates neuronal microtubule nucleation and development.
• Modulates osteoclast resorption activity and bone homeostasis.
• Influences autophagy and protein degradation pathways [1,2].
• Provides mechanistic basis for microtubule-targeting chemotherapies.
• Links post-translational modifications to cytoskeletal stability.
• Affects cell polarity and Sertoli cell function.
• Contributes to neurodegenerative disease mechanisms.
• Offers targets for cancer and bone disease drug discovery [4,7].
• Enables CRISPR-based functional genomics of microtubule regulators [1,2,6].
What Happens During negative regulation of microtubule polymerization or depolymerization?
Initiation by post-translational modifications
In simple terms: Chemical tags on tubulin can put a brake on microtubule growth.
Glutamylation is a post-translational modification that acts as a negative regulator of microtubule growth, directly reducing polymerization rates. This modification alters the interaction between tubulin dimers and microtubule-associated proteins, thereby suppressing dynamic instability.
Motor protein-mediated depolymerization
In simple terms: Motor proteins can walk along microtubules and pull them apart.
Kinesin-8 motor proteins can actively depolymerize microtubules, providing a molecular model for negative regulation of microtubule dynamics. Their ATP-dependent activity removes tubulin dimers from microtubule ends, reducing net polymer length.
Feedback loops in neuronal nucleation
In simple terms: Signals from the nucleus can tell the cytoplasm to slow microtubule formation.
A cytosol-to-nucleus feedback loop regulates neuronal microtubule nucleation, ensuring that microtubule formation is tuned to developmental needs. Disruption of this loop alters microtubule density and neuronal morphology.
Crosstalk with autophagy and protein degradation
In simple terms: The cell's recycling system can influence microtubule stability.
PIK3C3 controls Sertoli cell polarity through negative regulation of SCIN, linking autophagy regulation to microtubule-dependent processes. HYPK coordinates degradation of polyneddylated proteins by autophagy, which can indirectly affect microtubule dynamics.
Regulation by microtubule-associated proteins
In simple terms: Accessory proteins can bind microtubules and change their stability.
ARHGAP10 is a novel microtubule-associated protein that regulates osteoclast resorption activity, demonstrating that microtubule-associated proteins can negatively regulate dynamics in a cell-type-specific manner.
Key Genes Involved in GO:0031111 negative regulation of microtubule polymerization or depolymerization
The following genes and proteins have been experimentally linked to negative regulation of microtubule polymerization or depolymerization or to closely related microtubule dynamic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3C3 | Autophagy regulation and protein kinase activity; controls Sertoli cell polarity via SCIN | Links autophagy to microtubule-dependent cell polarity |
| SCIN | Actin severing and capping; target of PIK3C3 negative regulation | Mediates cytoskeletal crosstalk in Sertoli cells |
| HYPK | Coordinates degradation of polyneddylated proteins by autophagy | Connects protein degradation to microtubule dynamics |
| ARHGAP10 | Microtubule-associated protein; regulates osteoclast resorption | Novel regulator of microtubule dynamics in bone cells |
| Kinesin-8 family | ATP-dependent microtubule depolymerization | Model for motor-driven negative regulation |
| Tubulin glutamylases | Add glutamate chains to tubulin | Negative regulators of microtubule growth |
| Neuronal nucleation regulators | Cytosol-to-nucleus feedback loop | Controls neuronal microtubule nucleation |
| SCIN (scinderin) | Actin filament severing | Downstream effector of PIK3C3 in polarity |
| Autophagy-related proteins | Protein degradation | Indirect modulators of microtubule stability |
| Osteoclast microtubule regulators | Bone resorption | Therapeutic targets for bone disease |
| Microtubule-associated proteins (MAPs) | Stabilize or destabilize microtubules | General regulators of dynamic instability |
| Tubulin isotypes | Building blocks of microtubules | Substrates for post-translational regulation |
| Kinesin motors | Microtubule-based transport and depolymerization | Key effectors of negative regulation |
| Neuronal microtubule regulators | Nucleation and stabilization | Implicated in neurodegeneration |
| Sertoli cell polarity proteins | Cell polarity | Reproductive biology |
| Polyneddylated protein clearance factors | Protein quality control | Autophagy-microtubule crosstalk |
| ARHGAP10 effectors | Rho GTPase signaling | Osteoclast function |
How Is negative regulation of microtubule polymerization or depolymerization Regulated?
Negative regulation of microtubule polymerization or depolymerization is itself regulated by upstream signaling pathways. For example, PIK3C3 kinase activity controls autophagy and Sertoli cell polarity through negative regulation of SCIN, indicating that autophagy-related kinases can modulate microtubule-dependent processes. HYPK coordinates degradation of polyneddylated proteins by autophagy, suggesting that protein quality control pathways influence microtubule dynamics. Additionally, a cytosol-to-nucleus feedback loop regulates neuronal microtubule nucleation, providing a mechanism for transcriptional or nuclear signals to tune microtubule formation.
negative regulation of microtubule polymerization or depolymerization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Kinesin-8 | Cancer (mitotic defects) | Knockout in cancer cell lines; live-cell imaging |
| ARHGAP10 | Bone disorders (osteoclast resorption) | Knockout in osteoclast precursors; resorption assays |
| PIK3C3 | Autophagy-related pathologies; Sertoli cell polarity | Conditional knockout in mouse Sertoli cells |
| HYPK | Protein aggregation and autophagy disorders | Knockout in neuronal cell lines; autophagy flux assays |
| Neuronal nucleation regulators | Neurodegeneration | Knock-in of feedback-loop mutants in neurons |
Cancer and microtubule-targeting therapy
Microtubule dynamics are a validated target in oncology, and negative regulators of polymerization or depolymerization can influence sensitivity to microtubule-targeting drugs. Kinesin-8 motor proteins, which depolymerize microtubules, are potential therapeutic targets because their inhibition can alter mitotic spindle assembly and cell division.
Neurodegeneration and neuronal development
Neuronal microtubule nucleation is controlled by a cytosol-to-nucleus feedback loop, and disruption of this regulation may contribute to neurodegenerative diseases characterized by cytoskeletal defects. Proper negative regulation is essential for neuronal polarity and transport.
Bone disorders and osteoclast function
ARHGAP10 regulates osteoclast resorption activity as a microtubule-associated protein, linking negative regulation of microtubule dynamics to bone homeostasis. Dysregulation of this process may contribute to osteoporosis or other bone diseases.
Autophagy-related pathologies
PIK3C3 and HYPK are involved in autophagy and protein degradation, which can indirectly affect microtubule stability [1,2]. Defects in these pathways have been implicated in cancer, neurodegeneration, and metabolic disorders [1,2].
From negative regulation of microtubule polymerization or depolymerization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase microtubule polymerization? | CRISPR knockout in HeLa or neuronal cells followed by live-cell imaging [3,4] |
| Does a specific point mutation alter kinesin-8 depolymerization activity? | CRISPR point mutation knock-in in motor domain |
| Does tagging a microtubule-associated protein affect its localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of a negative regulator stabilize microtubules? | Doxycycline-inducible overexpression in cell lines |
| Does a feedback-loop gene control neuronal nucleation? | Knockout or knock-in in primary neurons |
| Does autophagy modulation affect microtubule dynamics? | CRISPR knockout of PIK3C3 or HYPK with microtubule tracking [1,2] |
How to Study the negative regulation of microtubule polymerization or depolymerization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Microtubule polymerization/depolymerization rates | Quantify negative regulation in CRISPR knockouts [3,4] |
| Mass spectrometry | Tubulin post-translational modifications | Identify glutamylation and other marks |
| CRISPR knockout screens | Gene essentiality and dynamics regulators | Discover negative regulators [1,2] |
| In vitro reconstitution | Motor-driven depolymerization | Test kinesin-8 activity |
| Immunofluorescence | Microtubule density and organization | Assess neuronal nucleation |
| Autophagy flux assays | Autophagic degradation | Link PIK3C3/HYPK to microtubules [1,2] |
| Osteoclast resorption assays | Bone resorption activity | Study ARHGAP10 function |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Test negative regulators |
Live-cell imaging of microtubule dynamics
Live-cell imaging using fluorescently labeled tubulin or microtubule plus-end tracking proteins (e.g., EB1) allows direct measurement of polymerization and depolymerization rates in cells with CRISPR-modified genes [3,4]. This method is essential for quantifying negative regulation in real time.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics can identify glutamylation and other post-translational modifications on tubulin that negatively regulate microtubule growth. This approach helps map the modification landscape in different cell types.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate microtubule polymerization or depolymerization [1,2]. Hits can be validated with targeted knockouts and imaging.
Biochemical reconstitution assays
In vitro reconstitution with purified tubulin, kinesin-8 motors, and modified tubulin can directly test depolymerization activity and the effects of post-translational modifications [3,4]. This provides mechanistic insight into negative regulation.
How CRISPR Can Be Used to Study GO:0031111 negative regulation of microtubule polymerization or depolymerization
Knockout
CRISPR knockout of candidate genes such as PIK3C3, HYPK, or ARHGAP10 can reveal whether they are required for negative regulation of microtubule polymerization or depolymerization [1,2,7]. Knockout cell lines are valuable for live-cell imaging and biochemical assays.
Point Mutation
Point mutation knock-in can dissect specific residues required for motor activity or post-translational modification. For example, mutating the catalytic domain of kinesin-8 can test its depolymerization function.
Knock-in
Knock-in of fluorescent tags or epitope tags at endogenous loci allows tracking of microtubule-associated proteins such as ARHGAP10 in real time. This approach preserves native regulation.
Overexpression
CRISPR activation or cDNA overexpression can test whether a candidate gene is sufficient to suppress microtubule dynamics. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports negative regulation of microtubule polymerization or depolymerization Research
Researchers studying negative regulation of microtubule polymerization or depolymerization-related genes often need to determine whether a candidate gene is causally involved in suppressing microtubule dynamics, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of microtubule polymerization or depolymerization research.
Frequently Asked Questions About negative regulation of microtubule polymerization or depolymerization
What is GO:0031111?
GO:0031111 is the Gene Ontology term for negative regulation of microtubule polymerization or depolymerization, defined as any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization or depolymerization.
What genes are involved in negative regulation of microtubule polymerization or depolymerization?
Genes such as PIK3C3, HYPK, ARHGAP10, kinesin-8 motors, and tubulin glutamylases have been linked to this process [1,2,3,4,7].
How does glutamylation negatively regulate microtubule growth?
Glutamylation is a post-translational modification that acts as a negative regulator of microtubule growth by altering tubulin interactions.
What is the role of kinesin-8 in microtubule depolymerization?
Kinesin-8 motor proteins actively depolymerize microtubules in an ATP-dependent manner, providing a model for negative regulation.
How is neuronal microtubule nucleation regulated?
A cytosol-to-nucleus feedback loop regulates neuronal microtubule nucleation, ensuring proper microtubule density.
What diseases are associated with defective microtubule regulation?
Cancer, neurodegeneration, and bone disorders have been linked to altered microtubule dynamics [4,6,7].
How can CRISPR be used to study microtubule negative regulators?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes [1,2,6].
What methods measure microtubule polymerization or depolymerization?
Live-cell imaging, in vitro reconstitution, and proteomics are commonly used [3,4].
What is the role of ARHGAP10 in microtubule dynamics?
ARHGAP10 is a microtubule-associated protein that regulates osteoclast resorption activity.
How does autophagy relate to microtubule regulation?
PIK3C3 and HYPK link autophagy and protein degradation to microtubule-dependent processes [1,2].
Conclusion
GO:0031111, negative regulation of microtubule polymerization or depolymerization, is a fundamental biological process that controls cytoskeletal dynamics through post-translational modifications, motor proteins, and feedback loops [3,4,6]. Its dysregulation is implicated in cancer, neurodegeneration, and bone disorders, making it a rich area for therapeutic targeting [4,6,7]. CRISPR-based models and advanced imaging methods are essential for dissecting the molecular players and translating these findings into clinical applications [1,2,6].
References
- 1. Wang K et al.. 2023. Autophagy regulation and protein kinase activity of PIK3C3 controls sertoli cell polarity through its negative regulation on SCIN (scinderin).. Autophagy 19(11):2934-2957 PMID: 37450577
- 2. Ghosh DK et al.. 2022. HYPK coordinates degradation of polyneddylated proteins by autophagy.. Autophagy 18(8):1763-1784 PMID: 34836490
- 3. Chen J et al.. 2023. Glutamylation is a negative regulator of microtubule growth.. Mol Biol Cell 34(7):ar70 PMID: 37074962
- 4. Xie P. 2024. A model of microtubule depolymerization by kinesin-8 motor proteins.. Adv Protein Chem Struct Biol 141:87-122 PMID: 38960488
- 6. Kumar N et al.. 2026. Identification of a cytosol-to-nucleus feedback loop that regulates neuronal microtubule nucleation.. J Cell Biol 225(3) PMID: 41524689
- 7. Jentschel L et al.. 2025. ARHGAP10 is a novel microtubule-associated protein that regulates the resorption activity of osteoclasts.. J Biol Chem 301(10):110668 PMID: 40889677
